Journal of Endocrinological Investigation

, Volume 37, Issue 5, pp 449–454

Pantoprazole may improve beta cell function and diabetes mellitus

  • F. Inci
  • M. Atmaca
  • M. Ozturk
  • S. Yildiz
  • R. Koceroglu
  • R. Sekeroglu
  • S. H. Ipekci
  • L. Kebapcilar
Original Article

DOI: 10.1007/s40618-013-0040-y

Cite this article as:
Inci, F., Atmaca, M., Ozturk, M. et al. J Endocrinol Invest (2014) 37: 449. doi:10.1007/s40618-013-0040-y

Abstract

Background

Proton pump inhibitors induce hypergastrinemia by suppressing gastric acidity. Gastrin has incretin-like stimulating actions on beta cells. Proton pump inhibitors have been shown to decrease glycosylated hemoglobin.

Aim

We aimed to observe changes in beta cell function in diabetic and non-diabetic subjects given pantoprazole for an acid-related ailment.

Methods

Seventy-nine male patients (38 non-diabetic and 41 type-2 diabetic receiving only metformin therapy) were followed for 12 weeks after pantoprazole 40 mg/day was given. Fasting plasma glucose, HbA1c, fasting insulin, Pancreatic B cell function (HOMA-B), proinsulin and c-peptide levels were measured before and after the treatment.

Results

In non-diabetic patients (n = 38), FPG decreased, whereas c-peptide, log-HOMA-B, increased significantly (p = 0.002, p = 0.03, p = 0.042, respectively) after 12 weeks of pantoprazole administration. In type 2 diabetic patients, FPG, HbA1c and weight decreased, whereas log-HOMA-B, c-peptide and log-proinsulin levels increased significantly after pantoprazole treatment (p = 0.003, p = 0.007, p < 0.001; p < 0.001; p = 0.017, p = 0.05, respectively). After pantoprazole treatment, pancreatic B-cell function was correlated with c-peptide and insulin and inversely with FBG and HbA1c levels in the whole group (r = 0.37, p = 0.001; r = 0.60, p < 0.001, r = −0.29, p = 0.011 and r = −0.28, p = 0.013, respectively). After pantoprazole treatment, HbA1c was correlated with FBG (r = 0.75, p < 0.001) and inversely with only log-HOMA-B level (r = −0.28, p = 0.013).

Conclusions

Pantoprazole administration seems to correlate with increased beta cell function. Pantoprazole administration improves HbA1c, HOMA-B, c-peptide and proinsulin levels. Since beta cell loss plays a significant role in the pathogenesis of type 2 diabetes, PPI-based therapies may be useful in the treatment of diabetes.

Keywords

Diabetes mellitus Pantoprazole HOMA-B C-peptide Insulin Proinsulin 

Copyright information

© Italian Society of Endocrinology (SIE) 2013

Authors and Affiliations

  • F. Inci
    • 1
  • M. Atmaca
    • 2
  • M. Ozturk
    • 2
  • S. Yildiz
    • 2
  • R. Koceroglu
    • 3
  • R. Sekeroglu
    • 3
  • S. H. Ipekci
    • 4
  • L. Kebapcilar
    • 4
    • 5
  1. 1.Department of Internal MedicineUniversity of Yuzuncu YilVanTurkey
  2. 2.Division of Endocrinology and Metabolism, Department of Internal MedicineUniversity of Yuzuncu YilVanTurkey
  3. 3.Department of BiochemistryUniversity of Yuzuncu YilVanTurkey
  4. 4.Division of Endocrinology and Metabolism, Department of Internal MedicineSelcuk UniversityKonyaTurkey
  5. 5.Department of Endocrinology and Metabolism, Faculty of MedicineSelcuk UniversityKonyaTurkey

Personalised recommendations